Literature DB >> 18381530

Trends in otitis media treatment failure and relapse.

Colin M Sox1, Jonathan A Finkelstein, Ruihua Yin, Ken Kleinman, Tracy A Lieu.   

Abstract

OBJECTIVES: The goals were to describe trends in acute otitis media, treatment failure, and relapse and in high-dose amoxicillin use and to determine whether treatment of acute otitis media with high-dose amoxicillin was associated with treatment failure or relapse.
METHODS: We conducted a retrospective study of acute otitis media visits made between 1996 and 2004 by children 2 months to 12 years of age in a large group practice, using computerized data. We defined acute otitis media as an otitis media visit with antibiotics dispensed (preceded by 30 days without otitis media visits), treatment failure as initiation of treatment with a second antibiotic before the first prescription was finished, and relapse as initiation of antibiotic treatment after the first prescription was finished but within 30 days after the index acute otitis media episode. The primary independent measure was high-dose amoxicillin (>70 mg/kg per day). We evaluated changes over time and determined whether high-dose amoxicillin use was associated with otitis media treatment failure or relapse.
RESULTS: We identified 111,335 acute otitis media visits over a 9-year period. The incidence of acute otitis media decreased from 385.1 visits per 1000 enrollees in 1996 to 188.8 visits per 1000 enrollees in 2004. The proportion of acute otitis media visits treated with high-dose amoxicillin increased from 1.7% in 1996 to 41.9% in 2004. Both otitis media treatment failure and relapse rates decreased from 1996 to 2004 (from 3.9% to 2.6% and from 9.2% to 8.9%, respectively). The odds of treatment failure or relapse did not differ between acute otitis media episodes treated with high-dose and low-dose amoxicillin.
CONCLUSIONS: During the past decade, acute otitis media, treatment failure, and relapse became less common and high-dose amoxicillin use increased. However, high-dose amoxicillin treatment did not reduce the risk of individual infections resulting in adverse outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381530     DOI: 10.1542/peds.2007-1565

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Trends in antibiotic use in Massachusetts children, 2000-2009.

Authors:  Sharon K Greene; Kenneth P Kleinman; Matthew D Lakoma; Sheryl L Rifas-Shiman; Grace M Lee; Susan S Huang; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2012-06-25       Impact factor: 7.124

2.  Resistance of non-typeable Haemophilus influenzae biofilms is independent of biofilm size.

Authors:  Jennifer L Reimche; Daniel J Kirse; Amy S Whigham; W Edward Swords
Journal:  Pathog Dis       Date:  2016-12-11       Impact factor: 3.166

Review 3.  A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children.

Authors:  Carlos G Grijalva; Stephen I Pelton
Journal:  Curr Opin Pediatr       Date:  2011-02       Impact factor: 2.856

Review 4.  Impact of pneumococcal conjugate vaccination on otitis media: a systematic review.

Authors:  Sylvia Taylor; Paola Marchisio; Anne Vergison; Julie Harriague; William P Hausdorff; Mark Haggard
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

5.  Pneumococcal conjugate vaccines for preventing acute otitis media in children.

Authors:  Alexandre C Fortanier; Roderick P Venekamp; Chantal Wb Boonacker; Eelko Hak; Anne Gm Schilder; Elisabeth Am Sanders; Roger Amj Damoiseaux
Journal:  Cochrane Database Syst Rev       Date:  2019-05-28

6.  Pneumococcal conjugate vaccines for preventing acute otitis media in children.

Authors:  Joline Lh de Sévaux; Roderick P Venekamp; Vittoria Lutje; Eelko Hak; Anne Gm Schilder; Elisabeth Am Sanders; Roger Amj Damoiseaux
Journal:  Cochrane Database Syst Rev       Date:  2020-11-24

7.  Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population.

Authors:  Mao-Che Wang; Ying-Piao Wang; Chia-Huei Chu; Tzong-Yang Tu; An-Suey Shiao; Pesus Chou
Journal:  ScientificWorldJournal       Date:  2015-03-09

8.  Pneumococcal conjugate vaccines and otitis media.

Authors:  Sylvia Taylor; Paola Marchisio; Anne Vergison; William P Hausdorff; Mark Haggard
Journal:  Int J Otolaryngol       Date:  2012-11-13

9.  Trends in antibiotic treatment of acute otitis media and treatment failure in children, 2000-2011.

Authors:  Leah J McGrath; Sylvia Becker-Dreps; Virginia Pate; M Alan Brookhart
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

10.  Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis.

Authors:  Alexandre C Fortanier; Roderick P Venekamp; Rebecca K Stellato; Elisabeth A M Sanders; Roger A M J Damoiseaux; Arno W Hoes; Anne M Schilder
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.